Literature DB >> 19473407

Efficacy and safety evaluation of sucrose-formulated recombinant factor VIII for Taiwanese patients with haemophilia A.

J-H Young, H-C Liu, E-J Hsueh, M-L Huang, C-T Peng, R-L Chen, M Maas-Enriquez, K Achilles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19473407     DOI： 10.1111/j.1365-2516.2009.02024.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  1 in total

1.  Sucrose-Formulated Recombinant Factor VIII Dosing Flexibility in Prophylaxis Regimens: Experience from Postmarketing Surveillance Studies.

Authors:  Thomas J Humphries; Stephan Rauchensteiner; Claudia Tückmantel; Alexander Pieper; Monika Maas Enriquez; Prasad Mathew
Journal:  Adv Hematol       Date:  2015-08-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.